What is the catalog number for DPPC-d71?

The catalog number for DPPC-d71 is HY-109506S7.

What sizes are available for DPPC-d71?

DPPC-d71 is available in the following size(s): 1 Each.

Is DPPC-d71 in stock?

DPPC-d71 is currently made to order / not held in immediate stock. Contact us for lead time.

Who manufactures DPPC-d71?

DPPC-d71 is manufactured by QuantiMol.

What is the estimated delivery time for DPPC-d71?

Estimated delivery time for DPPC-d71 is approximately 15 business day(s), depending on your location.

Where can I find the safety data sheet (SDS/MSDS) for DPPC-d71?

The safety data sheet for DPPC-d71 is available here: http://file.medchemexpress.com/batch_PDF/HY-109506S7/DPPC-d71-SDS-MedChemExpress.pdf.

DPPC-d71

DPPC-d71 is deuterium labeled DPPC. DPPC (129Y83) is a zwitterionic phosphoglyceride that can be used for the preparation of liposomal monolayers. DPPC-liposome serves effectively as a delivery vehicle for inducing immune responses against GSL antigen in

Product Specifications

CAS Number

474943-49-2

Product Name Alternative

129Y83-d71

UNSPSC

12352211

Target

Endogenous Metabolite; Isotope-Labeled Compounds

Type

Isotope-Labeled Compounds

Related Pathways

Metabolic Enzyme/Protease; Others

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Others

Purity

99.0

Solubility

10 mM in DMSO

Smiles

[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C(O[C@H](COC(C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])=O)COP(OCC[N+](C([2H])([2H])[2H])(C([2H])([2H])[2H])C([2H])([2H])[2H])([O-])=O)=O

Molecular Formula

C40H9D71NO8P

Molecular Weight

805.48

References & Citations

[1]Miller AD. Delivery of RNAi therapeutics: work in progress. Expert Rev Med Devices. 2013 Nov;10 (6) :781-811.|[2]Akiko Uemura, et al. Induction of immune responses against glycosphingolipid antigens: comparison of antibody responses in mice immunized with antigen associated with liposomes prepared from various phospholipids. J Vet Med Sci. 2005 Dec;67 (12) :1197-201.|[3]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-223.